Less than a third of FDA-mandated trials for drugs approved between 2015 and 2021 had been completed by May 2024.
WellSpan Health has been approved for a nearly $1 million funding award by the Patient-Centered Outcomes Research Institute ...
The annual Payment Notice prescribes standards and rules that govern insurers and health insurance Marketplaces under the ACA ...
Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...
At the forefront of precision dosing, Sharmeen leads DoseMe's efforts to transform personalized medicine from lab research to ...
Cerebral adrenoleukodystrophy (CALD) is a rare progressive, genetic brain disease that primarily presents in young boys, causing loss of neurological function and ultimately leading to early death.
Rigel Pharma surged 50.1% due to strong revenue drivers, strategic partnerships, and undervaluation, justifying a Strong Buy ...
Warren Bickel, whose addiction research and products helped put Roanoke, Virginia’s Fralin Biomedical Research Institute at ...
The FDA’s Rare Pediatric Disease designation is available to companies working to develop medicines for pediatric populations with rare diseases for which there are currently no other approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback